Summary & Overview
HCPCS P9023: Pooled Solvent/Detergent-Treated Frozen Plasma Unit
HCPCS Level II code P9023 denotes a unit of pooled, solvent/detergent–treated frozen plasma derived from multiple donors. This product is used in transfusion and plasma-derived therapy contexts where pathogen-reduced, pooled plasma is required. Nationally, coding and coverage for specialized plasma products like P9023 affect hospital supply chains, transfusion services, and reimbursement workflows for biologic blood products.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical and service context for P9023, typical sites of service, common modifiers used with HCPCS Level II billing for blood products, and notes on documentation expectations. The publication also outlines benchmarking and policy considerations relevant to plasma products, including coding clarity, payer coverage patterns, and areas where documentation may influence reimbursement. Where specific payer policies or benchmarks are not provided, the report indicates that data is not available in the input. This summary is intended for billing managers, transfusion service directors, and health policy analysts seeking a practical understanding of HCPCS Level II code P9023 and its role in hospital and transfusion practice.
Billing Code Overview
HCPCS Level II code P9023 describes plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit. This code represents a blood product prepared from pooled plasma donated by multiple individuals, treated with solvent/detergent processes to reduce viral risk, and provided as frozen units for transfusion or fractionation into plasma-derived therapies.
-
Service type: Blood product transfusion supply / biologic therapy supply
-
Typical site of service: Hospital inpatient and outpatient settings, blood banks, transfusion centers, and other acute care facilities where plasma units are stored and administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient receiving P9023 is an adult admitted to a hospital or transfusion center who requires replacement of clotting factors, plasma proteins, or volume support using pooled, solvent/detergent-treated frozen plasma units. Common clinical scenarios include management of massive transfusion for trauma, correction of coagulopathy prior to invasive procedures, treatment of liver disease–related coagulopathy, and replacement therapy for certain bleeding disorders when specific factor concentrates are unavailable. The typical workflow: a clinician documents indication (for example, active bleeding with elevated INR or requirement for invasive procedure), places an order in the electronic medical record for pooled solvent/detergent-treated frozen plasma, blood bank evaluates compatibility and issues thawed units, transfusion consent is confirmed, pretransfusion vitals and baseline coagulation tests are obtained, the unit labeled P9023 is transported to the bedside, transfusion is performed in an inpatient or outpatient infusion/transfusion center with monitoring for transfusion reactions, posttransfusion labs (INR, PT, hemoglobin) are repeated as indicated, and administration details are recorded in the medical record and billing system using P9023 per unit administered.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |